Identification of DRG-1 As a Melanoma-Associated Antigen Recognized by CD4(+) Th1 Cells

Immunotherapy has emerged as a promising strategy for the treatment of metastatic melanoma. Clinical studies have demonstrated the feasibility of cancer immunotherapy using tumor antigens recognized by CD8(+) T cells. However, the overall immune responses induced by these antigens are too weak and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiniwa, Yukiko, Li, Jiang, Wang, Mingjun, Sun, Chuang, Lee, Jeffrey E., Wang, Rong-Fu, Wang, Helen Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439028/
https://www.ncbi.nlm.nih.gov/pubmed/25993655
http://dx.doi.org/10.1371/journal.pone.0124094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439028/
https://www.ncbi.nlm.nih.gov/pubmed/25993655
http://dx.doi.org/10.1371/journal.pone.0124094

Ejemplares similares